StockData

IRulya Therapeutics Inc. (IRLA) stock

IRLANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$38.45+1.09 (+2.92%)

Close on Nov 17, 2026Market cap $39.11MP/E –Yield –

Earnings

IRulya Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 11, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
$2.31
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of IRulya Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Feb 11, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 13, 2026after the close––$2.31Release
Q2 FY2026ended Jun 30, 2026Aug 14, 2026before the open––-$12.31Release
Q4 FY2025ended Dec 31, 2025Feb 12, 2026before the open–––Filing
Q3 FY2025ended Sep 30, 2025Nov 12, 2025after the close–––Release
Q2 FY2025ended Jun 30, 2025Aug 11, 2025after the close––-$0.34Release
Q1 FY2025ended Mar 31, 2025May 13, 2025before the open––-$0.34Release
Q4 FY2024ended Dec 31, 2024Mar 24, 2025after the close–––Release
Q3 FY2024ended Sep 30, 2024Nov 13, 2024after the close––-$0.13Release
Q2 FY2024ended Jun 30, 2024Aug 13, 2024after the close–––Release
Q2 FY2023ended Jun 30, 2023Jul 24, 2023before the open–––Release
Q4 FY2022ended Dec 31, 2022Jan 30, 2023after the close–––Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

IRulya Therapeutics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When IRulya Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases IRulya Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Update
  3. Update
  4. News
  5. Results
  6. News
  7. News
  8. News
  9. Update
  10. Update
  11. Update
  12. Update
  13. Update
  14. News
  15. Results

See a number that looks wrong?